SCHEMBL6535794

SCHEMBL6535794

Cc1cc(-n2ccccc2=O)cc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 1/20 0.41
CYP1A2 P05177 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
BLM P54132 1/20 0.40
HSD17B10 Q99714 1/20 0.40
IDH1 O75874 1/20 0.40
TP53 P04637 2/20 0.39
GSR P00390 1/20 0.38
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
F10 P00742 1/20 0.37
COMT P21964 1/20 0.36
HTT P42858 2/20 0.36
FFAR4 Q5NUL3 1/20 0.35
FLT1 P17948 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17059032 0.83 COMT (0.49) CYP1A2ALDH1A1KDM4EHPGDBLM
SCHEMBL30613483 0.79 HTT (0.56) CYP1A2ALDH1A1TP53MAPTLMNA
SCHEMBL21241436 0.76 NR2E1 (0.41) TAS2R14CYP1A2ALDH1A1IDH1MAPT
SCHEMBL3305340 0.74 KDM4E (0.59) CYP1A2ALDH1A1KDM4EHPGDBLM
SCHEMBL92819 0.74 KDM4E (0.57) CYP1A2ALDH1A1KDM4EHPGDBLM
SCHEMBL10690095 0.73 GABRA2 (0.41) ALDH1A1HPGDMAPTLMNAF10
SCHEMBL6535778 0.73 HSP90AA1 (0.52) CYP1A2ALDH1A1KDM4EHPGDBLM
SCHEMBL17491390 0.71 CYP11B1 (0.38) ALDH1A1KDM4ELMNAF10NOTUM
SCHEMBL3349831 0.71 ALDH1A1 (0.36) CYP1A2ALDH1A1KDM4EHPGDBLM
SCHEMBL6535629 0.71 TSHR (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261338-A4 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY CYMAR INC (US) 2004-05-06 EP disclosed
EP-1261338-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY Cymar, Inc. (US) 2002-12-04 EP disclosed
WO-2001062253-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY CYMAR, INC. (US) 2001-08-30 WO disclosed